These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8035387)

  • 1. Strength in polymyositis and dermatomyositis: best outcome in patients treated early.
    Fafalak RG; Peterson MG; Kagen LJ
    J Rheumatol; 1994 Apr; 21(4):643-8. PubMed ID: 8035387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH; Hausner-Sypek DL; Weinblatt ME
    J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis].
    Ito S; Miyamae T; Imagawa T; Katakura S; Mori M; Tomono J; Ibe M; Mituda T; Aihara Y; Yokota S
    Ryumachi; 1998 Dec; 38(6):785-92. PubMed ID: 10047716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pathological investigation of polymyositis and dermatomyositis: report of 83 cases].
    Li Q; Lu BX; Zhou L; An SL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1139-40. PubMed ID: 12480599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis.
    Oddis CV; Medsger TA
    J Rheumatol; 1988; 15(5):807-11. PubMed ID: 3172094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis.
    McKendry RJ
    Arch Intern Med; 1987 Nov; 147(11):1989-91. PubMed ID: 3675101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscular strength as an index of response to therapy in childhood dermatomyositis.
    Resnick JS; Mammel M; Mundale MO; Kottke FJ
    Arch Phys Med Rehabil; 1981 Jan; 62(1):12-9. PubMed ID: 7458626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
    Adams EM; Pucino F; Yarboro C; Hicks JE; Thornton B; McGarvey C; Sonies BC; Bartlett ML; Villalba ML; Fleisher T; Plotz PH
    J Rheumatol; 1999 Feb; 26(2):352-60. PubMed ID: 9972969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis.
    Wang D; Zhang H; Cao M; Tang Y; Liang J; Feng X; Wang H; Hua B; Liu B; Sun L
    Ann Rheum Dis; 2011 Jul; 70(7):1285-8. PubMed ID: 21622775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method.
    Stoll T; Brühlmann P; Stucki G; Seifert B; Michel BA
    J Rheumatol; 1995 Mar; 22(3):473-7. PubMed ID: 7783064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum enzyme, myoglobin and muscle strength relationships in polymyositis and dermatomyositis.
    Kroll M; Otis J; Kagen L
    J Rheumatol; 1986 Apr; 13(2):349-55. PubMed ID: 3723497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis.
    Escalante A; Miller L; Beardmore TD
    J Rheumatol; 1993 Aug; 20(8):1340-4. PubMed ID: 8230016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis.
    Drouet B; Le Loët X; Vittecoq O; Nouvet G; Genevois A; Lauret P; Tron P; Menard JF; Czernichow P; Muir JF; Mallet E
    Rev Rhum Engl Ed; 1996 May; 63(5):321-30. PubMed ID: 8789877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
    Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of methylprednisolone pulse therapy in polymyositis/dermatomyositis.
    Bolosiu HD; Man L; Rednic S
    Adv Exp Med Biol; 1999; 455():349-57. PubMed ID: 10599369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab treatment in patients with refractory inflammatory myopathies.
    Mahler EA; Blom M; Voermans NC; van Engelen BG; van Riel PL; Vonk MC
    Rheumatology (Oxford); 2011 Dec; 50(12):2206-13. PubMed ID: 21571768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyositis/dermatomyositis: clinical features and outcome in 22 patients.
    Baron M; Small P
    J Rheumatol; 1985 Apr; 12(2):283-6. PubMed ID: 3875720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.
    Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
    Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyositis-dermatomyositis:25 years of follow-up of 50 patients disease course, treatment, prognostic factors.
    Chwalińska-Sadowska H; Małdykowa H
    Mater Med Pol; 1990; 22(3):213-8. PubMed ID: 2132429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.